Sale of ordinary shares held in treasury

RNS Number : 2090A
The MedicX Fund Limited
27 March 2012
 



 

 

For immediate release

27 March 2012

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

Sale of ordinary shares held in treasury

 

 

MedicX Fund (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, announces that today, Tuesday 27 March 2012, it sold for cash 500,000 ordinary shares of no par value in the Company.  The ordinary shares were sold out of treasury by the Company, at a price per share (before expenses) of 76.5 pence.

 

The net proceeds will be used in further pursuing the investment objectives of the Company.

 

Following this transaction, the Company has 263,645,780 ordinary shares in issue, of which 17,800,000 are held in treasury.  Accordingly, the total voting rights in issue will be 245,845,780.

 

 

End

 

 

For further information please contact:

 

MedicX Group:                                                               +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

 

Cannacord Genuity Limited:                                             +44 (0) 20 7523 8000

Andrew Zychowski/Helen Goldsmith

 

Buchanan                                                                      +44 (0) 20 7466 5000

Charles Ryland/Suzanne Brooks

  

MedicX Fund:                                                                 +44 (0) 1481 723 450

David Staples, Chairman

 

Information on MedicX Fund Limited

 

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 70 properties.

 

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 26 people operating across the UK.  

 

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSEAKDXAFSAEFF
UK 100

Latest directors dealings